NCT01533766View on ClinicalTrials.gov

A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

February 29, 2012

Conditions

Parent

Interventions

DRUG

CombiflexOmega

intravenously over 5 days infusion

DRUG

SmofKabiven

intravenously over 5 days infusion

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seoul

Sponsors

Lead Sponsor

JW Life Science

All Listed Sponsors

lead

JW Life Science

INDUSTRY